Renier J Brentjens

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Acute Lymphoblastic Leukemia

Mesenchymal Stem Cells

Top Venues

Nature medicine

Cancer immunology research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Winson Cai, Kento Tanaka, Xiaoli Mi, Vinagolu K Rajasekhar, Jonathan F Khan, Sarah Yoo, Elisa De Stanchina, Jahan A Rahman, Serena Mathew, Parwiz Abrahimi, Sydney Souness, Terence J Purdon, James R McDowell, Jeremy Meyerberg, Takeshi Fujino, John H Healey, Omar Abdel-Wahab, David A Scheinberg, Renier J Brentjens, Anthony F Daniyan
Augmenting CAR T Cell Functions with LIGHT. Cancer immunology research (2024)
Winson Cai, Kento Tanaka, Xiaoli Mi, Vinagolu K Rajasekhar, Jonathan F Khan, Sarah Yoo, Elisa De Stanchina, Jahan A Rahman, Serena Mathew, Parwiz Abrahimi, Sydney Souness, Terence J Purdon, James R McDowell, Jeremy Meyerberg, Takeshi Fujino, John H Healey, Omar Abdel-Wahab, David A Scheinberg, Renier J Brentjens, Anthony F Daniyan
Augmenting CAR T Cell Functions with LIGHT. Cancer immunology research (2024)
Winson Cai, Kento Tanaka, Xiaoli Mi, Vinagolu K Rajasekhar, Jonathan F Khan, Sarah Yoo, Elisa De Stanchina, Jahan A Rahman, Serena Mathew, Parwiz Abrahimi, Sydney Souness, Terence J Purdon, James R McDowell, Jeremy Meyerberg, Takeshi Fujino, John H Healey, Omar Abdel-Wahab, David A Scheinberg, Renier J Brentjens, Anthony F Daniyan
Augmenting CAR T Cell Functions with LIGHT. Cancer immunology research (2024)
Jae H Park, Karthik Nath, Sean M Devlin, Craig S Sauter, Maria Lia Palomba, Gunjan Shah, Parastoo Dahi, Richard J Lin, Michael Scordo, Miguel-Ángel Perales, Roni Shouval, Ana Alarcon Tomas, Elizabeth Cathcart, Elena Mead, Bianca D Santomasso, Andrei I Holodny, Renier J Brentjens, Isabelle Riviere, Michel Sadelain
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results. Nature medicine (2023)
Leila Amini, Sara K Silbert, Shannon L Maude, Loretta J Nastoupil, Carlos Almeida Ramos, Renier J Brentjens, Craig S Sauter, Nirali N Shah, Mohamed Abou-El-Enein
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion. Nature reviews. Clinical oncology 19 (5) (2022)
Marco L Davila, Renier J Brentjens
CAR T cell therapy: looking back and looking forward. Nature cancer 3 (12) (2022)
Marco L Davila, Renier J Brentjens
CAR T cell therapy: looking back and looking forward. Nature cancer 3 (12) (2022)
Marco L Davila, Renier J Brentjens
CAR T cell therapy: looking back and looking forward. Nature cancer 3 (12) (2022)
Marco L Davila, Renier J Brentjens
CAR T cell therapy: looking back and looking forward. Nature cancer 3 (12) (2022)
Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V Amelsberg, Sean M Devlin, Raymone Pajarillo, John B Slingerland, Silvia Beghi, Pamela S Herrera, Paul Giardina, Annelie Clurman, Emmanuel Dwomoh, Gabriel Armijo, Antonio L C Gomes, Eric R Littmann, Jonas Schluter, Emily Fontana, Ying Taur, Jae H Park, Maria Lia Palomba, Elizabeth Halton, Josel Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel-Ángel Perales, Craig W Freyer, Alfred Garfall, Shannon Gier, Sunita Nasta, Daniel Landsburg, James Gerson, Jakub Svoboda, Justin Cross, Elise A Chong, Sergio Giralt, Saar I Gill, Isabelle Riviere, David L Porter, Stephen J Schuster, Michel Sadelain, Noelle Frey, Renier J Brentjens, Carl H June, Eric G Pamer, Jonathan U Peled, Andrea Facciabene, Marcel R M van den Brink, Marco Ruella
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nature medicine (2022)
Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V Amelsberg, Sean M Devlin, Raymone Pajarillo, John B Slingerland, Silvia Beghi, Pamela S Herrera, Paul Giardina, Annelie Clurman, Emmanuel Dwomoh, Gabriel Armijo, Antonio L C Gomes, Eric R Littmann, Jonas Schluter, Emily Fontana, Ying Taur, Jae H Park, Maria Lia Palomba, Elizabeth Halton, Josel Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel-Ángel Perales, Craig W Freyer, Alfred Garfall, Shannon Gier, Sunita Nasta, Daniel Landsburg, James Gerson, Jakub Svoboda, Justin Cross, Elise A Chong, Sergio Giralt, Saar I Gill, Isabelle Riviere, David L Porter, Stephen J Schuster, Michel Sadelain, Noelle Frey, Renier J Brentjens, Carl H June, Eric G Pamer, Jonathan U Peled, Andrea Facciabene, Marcel R M van den Brink, Marco Ruella
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nature medicine 28 (4) (2022)
Karlo Perica, Jessica Flynn, Kevin J Curran, Isabelle Rivere, Xiuyan Wang, Brigitte Senechal, Elizabeth Halton, Claudia Diamonte, John Pineda, Yvette Bernal, Mithat Gonen, Michel Sadelain, Renier J Brentjens, Jae H Park
Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia. Leukemia 35 (11) (2021)
Rosa Sottile, M Kazim Panjwani, Colleen M Lau, Anthony F Daniyan, Kento Tanaka, Juliet N Barker, Renier J Brentjens, Joseph C Sun, Jean-Benoît Le Luduec, Katharine C Hsu
Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity. Science immunology 6 (63) (2021)
Thomas J Gardner, J Peter Lee, Christopher M Bourne, Dinali Wijewarnasuriya, Nihar Kinarivala, Keifer G Kurtz, Broderick C Corless, Megan M Dacek, Aaron Y Chang, George Mo, Kha M Nguyen, Renier J Brentjens, Derek S Tan, David A Scheinberg
Engineering CAR-T cells to activate small-molecule drugs in situ. Nature chemical biology 18 (2) (2021)
Eric L Smith, Kim Harrington, Mette Staehr, Reed Masakayan, Jon Jones, Thomas J Long, Khong Y Ng, Majid Ghoddusi, Terence J Purdon, Xiuyan Wang, Trevor Do, Minh Thu Pham, Jessica M Brown, Carlos Fernandez De Larrea, Eric Olson, Elizabeth Peguero, Pei Wang, Hong Liu, Yiyang Xu, Sarah C Garrett-Thomson, Steven C Almo, Hans-Guido Wendel, Isabelle Riviere, Cheng Liu, Blythe Sather, Renier J Brentjens
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells. Science translational medicine 11 (485) (2020)
Nicholas F Kuhn, Andrea V Lopez, Xinghuo Li, Winson Cai, Anthony F Daniyan, Renier J Brentjens
CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function. Nature communications 11 (1) (2020)
Mei Song, Oladapo O Yeku, Sarwish Rafiq, Terence Purdon, Xue Dong, Lijing Zhu, Tuo Zhang, Huan Wang, Ziqi Yu, Junhua Mai, Haifa Shen, Briana Nixon, Ming O Li, Renier J Brentjens, Xiaojing Ma
Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nature communications 11 (1) (2020)